Skip to content

Effect of Shunthi Tablet in Amajirna

Critical study of Rogotpatti Sidhdhanta and its application in management of Amajirna

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/01/006575
Enrollment
30
Registered
2016-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Indigestion

Interventions

Intervention1: Shunthi Tablet: 2 tab 500 mg each thrice per day after meal duration 10 days Control Intervention1: Shunthi Tablet: 2 tab 500 mg each thrice per day after meal duration 10 days

Sponsors

IPGT RA GAU Jamnagar India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Amajirna mentioned in classics Patients having age between 20 -50 years Patients will be selected without any bar of race religion and sex

Exclusion criteria

Exclusion criteria: Patients suffering from chronic major illness like Jaundice AIDS Cancer Tuberculosis Diabetes Mellitus etc Patient having symptoms of Vidagdhajirna Vishtabdhajirna Rasasheshajirna and Dinapaki Ajirna Patient having age less than 20 years and more than 50 years

Design outcomes

Primary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the signs and symptoms based on the standard pattern will be applied before and after treatmentTimepoint: 10 days

Secondary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the signs and symptoms based on the standard pattern will be applied before and after treatmentTimepoint: less than 10 days

Countries

India

Contacts

Public ContactProf M K Vyas

IPGT RA Jamnagar Gujarat

asbaghel2001@yahoo.com9426433575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026